High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in migraine prophylaxis: An open labeled study

Neurological Research

Volumn 34, Issue 6, 2012, Pages 547-551

  Misra, Usha K ^a   Kalita, Jayantee ^a   Bhoi, Sanjeev K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Magnetic stimulation; Migraine; Non pharmacological treatment; Outcome; Prophylaxis; rTMS

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OPEN STUDY; PATIENT SELECTION; PROPHYLAXIS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864088409     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000045     Document Type: Article

References (23)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-9.
2. Brighina F, Piazza A, Vitello G, Aloisio A, Palermo A, Daniele O, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227:67-71.
3. Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006;7:341-6.
4. Lipton RB, Pearlman SH. Transcranial magnetic simulation in the treatment of migraine. Neurotherapeutics. 2010;7:204-12.
5. Teepker M, Hotzel J, Timmesfeld N, Reis J, Mylius V, Haag A, et al. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia. 2010;30:137-44.
6. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen NA, Andersen AR, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990;28:791-8.
7. Reuter U, Sanchez del Rio M, Moskowitz MA. Experimental models in migraine. Funct Neurol. 2000;3:9-18.
8. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658-660.
9. May A. New insights into headache: an update on functional and structural imaging findings. Nat Rev Neurol. 2009;5:199-209.
10. Coppola G, Currà A, Di Lorenzo C, Parisi V, Gorini M, Sava SL, et al. Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol. 2010;30:126.
11. Gawel M, Connolly JF, Rose FC. Migraine patients exhibit abnormalities in the visual evoked potential. Headache. 1983;23:49-52.
12. Kropp P, Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia. 1993;13:37-41.
13. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48:1398-403.
14. Pascual-Leone A, Valls-Sole J, Hernandez S, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994;117:847-58.
15. Headache Classification Committee of the International Headache Society. The international classification of the headache disorders, 2nd edn. Cephalalgia. 2004;24:1-160.
16. Piovesan EJ, Silberstein SD. Diagnostic headache criteria and instruments. In: Herndon RM, editor. Handbook of neurologic rating scales. 2nd ed. New York: Demos Medical Publishing, Inc; 2006. p. 297-345.
17. Adelman JU, Lipton RB, Ferrari MD, Diener HC, McCarroll KA, Vandormael K, et al. Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology. 2001;57:1377-83.
18. Misra UK, Kalita J, Yadav RK. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. J Headache Pain. 2007;8:175-179.
19. Brighina F, de Tommaso M, Giglia F, Scalia S, Cosentino G, Puma A, et al. Modulation of pain perception by transcranial magnetic stimulation of left prefrontal cortex. J Headache Pain. 2011;12:185-91.
20. Day BL, Dressler D, Maertens de Noordhout A, Marsden CD, Nakashima K, Rothwell JC, et al. Electrical and magnetic stimulation of human motor cortex; surface EMG and single motor unit response. J Physiol (Lond). 1989;412:449-73.
21. Keck ME, Welt T, Muller MB, Erhardt A, Ohl F, Toschi N, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 2002;43:101-9.
22. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21:RC157.
23. André-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain. 2011;152:1233-7.